Milos Gojkovic
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The factor inhibiting HIF regulates T cell differentiation and anti-tumour efficacy.
Journal: Frontiers in immunology
Published: September 13, 2023
MLKL activity requires a splicing-regulated, druggable intramolecular interaction.
Journal: Molecular cell
Published: September 12, 2023
Infiltration of Tumors Is Regulated by T cell-Intrinsic Nitric Oxide Synthesis.
Journal: Cancer immunology research
Published: May 14, 2022
Oxygen-Mediated Suppression of CD8+ T Cell Proliferation by Macrophages: Role of Pharmacological Inhibitors of HIF Degradation.
Journal: Frontiers in immunology
Published: November 25, 2020
Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy.
Journal: Cancer immunology research
Published: June 30, 2020
Cytotoxic T-cells mediate exercise-induced reductions in tumor growth.
Journal: eLife
Published: June 14, 2020
Deregulated hypoxic response in myeloid cells: A model for high-altitude pulmonary oedema (HAPE).
Journal: Acta physiologica (Oxford, England)
Published: October 30, 2019
Glycolytic Response to Inflammation Over Time: Role of Myeloid HIF-1alpha.
Journal: Frontiers in physiology
Published: May 19, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026